Eye News and Research

Latest Eye News and Research

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to begin two Phase II clinical studies of ALG-1001.

10 Oct 2013

Paragon BioTeck, Horus Pharma sign distribution agreement for Ilast range of products

Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast range of its medical-grade ocular hygiene and lid care products within the United States; it begins on an exclusive basis this month.

10 Oct 2013

Dry eye disease symptom change independent of tear osmolarity

Tear osmolarity is a poor indicator of treatment response in patients with dry eye disease (DED), suggests research published in the American Journal of Ophthalmology.

9 Oct 2013

Iscreen Vision raises $4.0 million in series B funding round

iScreen Vision, Inc. (www.iscreenvision.com), a leading provider of pediatric vision screening equipment and services, today announced it raised $4.0 million in a Series B funding round led by MB Venture Partners.

9 Oct 2013

Gemcitabine drug improves survival rates in patients with pancreatic cancer

Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease-free survival, compared with observation alone, according to a study in the October 9 issue of JAMA.

9 Oct 2013

Retinitis pigmentosa test identifies mutation found in Ashkenazi Jewish population

You might not think to look to a urine test to diagnose an eye disease. But a new Duke University study says it can link what is in a patient's urine to gene mutations that cause retinitis pigmentosa, or RP, an inherited, degenerative disease that results in severe vision impairment and often blindness. The findings appear online in the Journal of Lipid Research.

9 Oct 2013

Survey reveals 60% of Americans report of having Silicon Valley Syndrome

LUMO BodyTech, the makers of the LUMOback smart posture and movement feedback system, today announced national survey results revealing a widespread phenomenon LUMO calls 'Silicon Valley Syndrome'.

9 Oct 2013

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein.

9 Oct 2013

Depression impairs sleep in breast cancer, but being married helps

Women with metastatic breast cancer are more likely to experience sleep disturbances if they are depressed or single, researchers report.

8 Oct 2013

Diabetic retinopathy incidence in upward trend

Retinal damage is one of the most common complications of diabetes, affecting about 90 percent of type 1 diabetics and 75 percent of type 2 diabetics. According to the World Health Organization (WHO), diabetic retinopathy is the leading cause of blindness in adults of working age, and its incidence is showing an upward trend.

8 Oct 2013

Subtle body cues allow people to identify others when faces are difficult to differentiate

Subtle body cues allow people to identify others with surprising accuracy when faces are difficult to differentiate. This skill may help researchers improve person-recognition software and expand their understanding of how humans recognize each other.

8 Oct 2013

GOP rank-and-file push to reopen federal gov't, eye medical device tax repeal instead

Some Republicans are moving away from efforts to repeal the entire health law and are turning their focus instead to repealing the health law's medical-device tax and reopening the federal government.

5 Oct 2013

Researchers reveals mechanism of sodium-potassium pump in cell

It's not visible to the naked eye and you can't feel it, but up to 40 per cent of your body's energy goes into supplying the microscopic sodium-potassium pump with the energy it needs. The pump is constantly doing its job in every cell of all animals and humans. It works much like a small battery which, among other things, maintains the sodium balance which is crucial to keep muscles and nerves working.

5 Oct 2013

Study shows precision medicine provides better treatment options for mentally ill person

A multidisciplinary team led by a geneticist and psychiatrist from Cold Spring Harbor Laboratory's (CSHL) Stanley Institute for Cognitive Genomics today publish a paper providing a glimpse of both the tremendous power and the current limitations of what is sometimes called "precision medicine."

5 Oct 2013

Trial to determine effectiveness of sun protection program for children of melanoma survivors

Children of melanoma survivors were more likely to wear hats and re-apply sunscreen after receiving a multi-media informational program designed specifically for them. These new findings were included in research published in the journal of Cancer Epidemiology, Biomarkers and Prevention - a publication of the American Association for Cancer Research.

5 Oct 2013

Designer Baby Patent Awarded To 23Andme

...

4 Oct 2013

Researchers identify link between neuronal activity in lateral hypothalamus and state of REM sleep

A team of scientists led by Dr. Antoine Adamantidis, a researcher at the Douglas Mental Health University Institute and an assistant professor at McGill University, has released the findings from their latest study, which will appear in the October issue of the prestigious scientific journal Nature Neuroscience.

3 Oct 2013

Eye News and Research

Latest Eye News and Research

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Paragon BioTeck, Horus Pharma sign distribution agreement for Ilast range of products

Dry eye disease symptom change independent of tear osmolarity

Iscreen Vision raises $4.0 million in series B funding round

Gemcitabine drug improves survival rates in patients with pancreatic cancer

Retinitis pigmentosa test identifies mutation found in Ashkenazi Jewish population

Survey reveals 60% of Americans report of having Silicon Valley Syndrome

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Depression impairs sleep in breast cancer, but being married helps

Diabetic retinopathy incidence in upward trend

Subtle body cues allow people to identify others when faces are difficult to differentiate

GOP rank-and-file push to reopen federal gov't, eye medical device tax repeal instead

Researchers reveals mechanism of sodium-potassium pump in cell

Study shows precision medicine provides better treatment options for mentally ill person

Trial to determine effectiveness of sun protection program for children of melanoma survivors

Designer Baby Patent Awarded To 23Andme

Researchers identify link between neuronal activity in lateral hypothalamus and state of REM sleep

Short-term hearing loss during childhood may lead to persistent hearing deficits

Notices about Medicare advantage changes coming

Research findings could help improve treatment for patients with chronic dizziness

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye News and Research

Latest Eye News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in